Gaucher disease with parkinsonian manifestations: Does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?

N. Tayebi; J. Walker; B. Stubblefield; E. Orvisky; M. E. LaMarca; K. Wong; H. Rosenbaum; R. Schiffmann; B. Bembi; E. Sidransky

doi:10.1016/S1096-7192(03)00071-4

Gaucher disease with parkinsonian manifestations: Does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?

N. Tayebi, J. Walker, B. Stubblefield, E. Orvisky, M. E. LaMarca, K. Wong, H. Rosenbaum, R. Schiffmann, B. Bembi, E. Sidransky

Research output: Contribution to journal › Article › peer-review

221 Scopus citations

Abstract

Among the phenotypes associated with Gaucher disease, the deficiency of glucocerebrosidase, are rare patients with early onset, treatment-refractory parkinsonism. Sequencing of glucocerebrosidase in 17 such patients revealed 12 different genotypes. Fourteen patients had the common "non-neuronopathic" N370S mutation, including five N370S homozygotes. While brain glucosylsphingosine levels were not elevated, Lewy bodies were seen in the four brains available for study. The shared clinical and neuropathologic findings in this subgroup suggest that the deficiency in glucocerebrosidase may contribute to a vulnerability to parkinsonism.

Original language	English (US)
Pages (from-to)	104-109
Number of pages	6
Journal	Molecular Genetics and Metabolism
Volume	79
Issue number	2
DOIs	https://doi.org/10.1016/S1096-7192(03)00071-4
State	Published - Jun 1 2003
Externally published	Yes

Keywords

Gaucher disease
Genotype/phenotype correlation
Glucocerebrosidase
Lewy body
Metaxin
Modifier gene
Parkinsonism

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Biochemistry
Molecular Biology
Genetics
Endocrinology

Access to Document

10.1016/S1096-7192(03)00071-4

Cite this

Tayebi, N., Walker, J., Stubblefield, B., Orvisky, E., LaMarca, M. E., Wong, K., Rosenbaum, H., Schiffmann, R., Bembi, B., & Sidransky, E. (2003). Gaucher disease with parkinsonian manifestations: Does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Molecular Genetics and Metabolism, 79(2), 104-109. https://doi.org/10.1016/S1096-7192(03)00071-4

Gaucher disease with parkinsonian manifestations : Does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? / Tayebi, N.; Walker, J.; Stubblefield, B.; Orvisky, E.; LaMarca, M. E.; Wong, K.; Rosenbaum, H.; Schiffmann, R.; Bembi, B.; Sidransky, E.

In: Molecular Genetics and Metabolism, Vol. 79, No. 2, 01.06.2003, p. 104-109.

Research output: Contribution to journal › Article › peer-review

Tayebi, N, Walker, J, Stubblefield, B, Orvisky, E, LaMarca, ME, Wong, K, Rosenbaum, H, Schiffmann, R, Bembi, B & Sidransky, E 2003, 'Gaucher disease with parkinsonian manifestations: Does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?', Molecular Genetics and Metabolism, vol. 79, no. 2, pp. 104-109. https://doi.org/10.1016/S1096-7192(03)00071-4

@article{1811fbe3299544199b93a005c3bbb873,

title = "Gaucher disease with parkinsonian manifestations: Does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?",

abstract = "Among the phenotypes associated with Gaucher disease, the deficiency of glucocerebrosidase, are rare patients with early onset, treatment-refractory parkinsonism. Sequencing of glucocerebrosidase in 17 such patients revealed 12 different genotypes. Fourteen patients had the common {"}non-neuronopathic{"} N370S mutation, including five N370S homozygotes. While brain glucosylsphingosine levels were not elevated, Lewy bodies were seen in the four brains available for study. The shared clinical and neuropathologic findings in this subgroup suggest that the deficiency in glucocerebrosidase may contribute to a vulnerability to parkinsonism.",

keywords = "Gaucher disease, Genotype/phenotype correlation, Glucocerebrosidase, Lewy body, Metaxin, Modifier gene, Parkinsonism",

author = "N. Tayebi and J. Walker and B. Stubblefield and E. Orvisky and LaMarca, {M. E.} and K. Wong and H. Rosenbaum and R. Schiffmann and B. Bembi and E. Sidransky",

year = "2003",

month = jun,

day = "1",

doi = "10.1016/S1096-7192(03)00071-4",

language = "English (US)",

volume = "79",

pages = "104--109",

journal = "Biochemical Medicine and Metabolic Biology",

issn = "1096-7192",

publisher = "Academic Press Inc.",

number = "2",

}

TY - JOUR

T1 - Gaucher disease with parkinsonian manifestations

T2 - Does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?

AU - Tayebi, N.

AU - Walker, J.

AU - Stubblefield, B.

AU - Orvisky, E.

AU - LaMarca, M. E.

AU - Wong, K.

AU - Rosenbaum, H.

AU - Schiffmann, R.

AU - Bembi, B.

AU - Sidransky, E.

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Among the phenotypes associated with Gaucher disease, the deficiency of glucocerebrosidase, are rare patients with early onset, treatment-refractory parkinsonism. Sequencing of glucocerebrosidase in 17 such patients revealed 12 different genotypes. Fourteen patients had the common "non-neuronopathic" N370S mutation, including five N370S homozygotes. While brain glucosylsphingosine levels were not elevated, Lewy bodies were seen in the four brains available for study. The shared clinical and neuropathologic findings in this subgroup suggest that the deficiency in glucocerebrosidase may contribute to a vulnerability to parkinsonism.

AB - Among the phenotypes associated with Gaucher disease, the deficiency of glucocerebrosidase, are rare patients with early onset, treatment-refractory parkinsonism. Sequencing of glucocerebrosidase in 17 such patients revealed 12 different genotypes. Fourteen patients had the common "non-neuronopathic" N370S mutation, including five N370S homozygotes. While brain glucosylsphingosine levels were not elevated, Lewy bodies were seen in the four brains available for study. The shared clinical and neuropathologic findings in this subgroup suggest that the deficiency in glucocerebrosidase may contribute to a vulnerability to parkinsonism.

KW - Gaucher disease

KW - Genotype/phenotype correlation

KW - Glucocerebrosidase

KW - Lewy body

KW - Metaxin

KW - Modifier gene

KW - Parkinsonism

UR - http://www.scopus.com/inward/record.url?scp=12444296116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12444296116&partnerID=8YFLogxK

U2 - 10.1016/S1096-7192(03)00071-4

DO - 10.1016/S1096-7192(03)00071-4

M3 - Article

C2 - 12809640

AN - SCOPUS:12444296116

VL - 79

SP - 104

EP - 109

JO - Biochemical Medicine and Metabolic Biology

JF - Biochemical Medicine and Metabolic Biology

SN - 1096-7192

IS - 2

ER -

Gaucher disease with parkinsonian manifestations: Does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this